Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

Shares of Figure Technology Solutions, Inc. dropped steeply on Monday following the release of preliminary Q4 operating data, offering a first glimpse into its loan marketplace and crypto-related offerings. The Nasdaq-listed stock slipped 9.6% to $52.50, hitting a low of $49.10 and peaking near $58.67 earlier in the session.

12 January 2026

NASDAQ:FIGR·Stock Market·Technology

Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

Bread Financial Holdings’ shares dropped 10.8% to $71.65 in afternoon trading Monday, hitting a low of $70.06 earlier in the session.

12 January 2026

Interest Rates·NASDAQ:BFH·NYSE:AXP·NYSE:COF·NYSE:SYF·Stock Market

GeneDx (WGS) stock dives on 2026 guidance despite strong 2025 prelims — what to watch next

Shares of GeneDx Holdings Corp dropped roughly 14% Monday following the release of its 2026 outlook and preliminary results for 2025. The stock slipped $19.64 to trade at $115.75 in afternoon sessions.

12 January 2026

Biotechnology·Stock Market

Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

Lemonade Inc shares surged 7.7% to $85.81 on Monday, pushing higher amid a wave of buying in volatile growth stocks. Earlier in the day, the online insurer’s stock hit $85.99.

12 January 2026

Earnings Reports·NASDAQ:LMND·Stock Market

Sarepta stock sinks as Elevidys sales miss, flu delays spill into 2026

Sarepta Therapeutics shares dropped roughly 13% to $20.73 in Monday afternoon trading following a disappointing sales forecast for its Duchenne muscular dystrophy gene therapy, Elevidys, in the fourth quarter.

12 January 2026

NASDAQ:SRPT·Pharmaceutical News

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Shares of Abercrombie & Fitch Co dropped 17.3% to $103.26 in afternoon trading Monday, following a cut to its full-year sales growth forecast and a more cautious holiday-quarter outlook. The stock had climbed as high as $124.75 earlier before falling to a session low of $98.87.

12 January 2026

NASDAQ:ANF·Stock Market

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio Inc shares tumbled almost 18% on Monday following news of a licensing deal with Japan’s Eisai and initial sales data for its lung-cancer treatment. The stock slipped 17.7% to $6.62, after fluctuating between $8.34 and $6.32 on roughly 11.4 million shares traded.

12 January 2026

Biotechnology·Earnings Reports·NASDAQ:NUVB·Stock Market·TSX:4523

Apellis (APLS) stock slides 15% after $689 mln 2025 revenue preview at JPM conference

Apellis Pharmaceuticals shares dropped almost 15% Monday following the release of preliminary 2025 U.S. sales numbers ahead of its J.P. Morgan Healthcare Conference update. The move put the stock in focus as biotech firms roll out early guidance for the year.

12 January 2026

Earnings Reports·NASDAQ:APLS·Stock Market

First Majestic Silver stock jumps 7% as silver rips to a fresh record — what investors watch next

First Majestic Silver Corp's shares climbed roughly 7% to close at $20.24 on Monday, gaining $1.33 amid a broader upswing in precious metals that boosted silver miners. Trading volume topped 20 million shares, with prices fluctuating between $19.70 and $20.60.

12 January 2026

Stock Market·TSX:FR

Sibanye Stillwater stock jumps as gold cracks $4,600, putting Jan. 29 strategy update in play

Sibanye Stillwater Limited’s U.S.-listed shares climbed roughly 7.3% to $16.79 in Monday afternoon trading, extending gains amid a rally in gold and other precious metals.

12 January 2026

Gold·NYSE:SBGL·Stock Market

Nebius (NBIS) stock jumps on report of 800MW Kansas City-area data center plan

Nebius Group N.V. shares surged roughly 10% Monday following reports that the AI infrastructure company plans to build an 800-megawatt data center campus near Kansas City, Missouri. The stock climbed 10.2% to $107.87 in afternoon trading, up from Friday’s close of $97.93.

12 January 2026

Data Centers·NASDAQ:NBIS·Stock Market

Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage shares jumped 7.9% on Monday, closing at $72.29. The move added to a volatile start for U.S. storage-related stocks, with investors shifting focus toward AI infrastructure plays.

12 January 2026

Earnings Reports·NASDAQ:PSTG·Stock Market·Technology

Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields shares rose Monday, lifted by a strong surge in gold prices that boosted the entire sector.

12 January 2026

Earnings Reports·Gold·NYSE:AEM·NYSE:AU·NYSE:GFI·NYSE:NEM·NYSE:WPM·Stock Market

IREN Limited stock pops 10% as bitcoin firms and CPI risk hangs over crypto names

IREN Limited shares jumped 10.5% to $50.85 in afternoon trading, hitting a session high of $50.95 earlier. The Nasdaq-listed stock climbed $4.82 from Friday’s close, with volume topping 35 million shares.

12 January 2026

Bitcoin·Cryptocurrency·NASDAQ:IREN.O·Stock Market

Nextpower (NXT) stock jumps on Saudi joint venture launch and 12‑GW factory plan

Nextpower Inc shares surged roughly 9% on Monday following the announcement of a completed Saudi joint venture and plans for a new manufacturing facility in the kingdom. The stock traded as high as $99.70 before settling up 9.3% at $99.62 in early afternoon trading, bouncing between $89.95 and $99.70.

12 January 2026

NASDAQ:NXT·Renewable Energy·Stock Market

Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Shares of Twist Bioscience Corp jumped roughly 8% Monday following a preliminary first-quarter revenue report that beat expectations. The synthetic DNA company’s stock climbed 7.8% to $38.07 in afternoon trading, trading between $34.51 and $39.80 earlier in the session.

12 January 2026

Biotechnology·Earnings Reports·NASDAQ:TWST

Powell Industries stock jumps as Wall Street Zen upgrade puts POWL back in play

Shares of Powell Industries, Inc. jumped 6.6% to $389.74 in early afternoon trading on Monday, hitting an intraday peak of $396.80. Roughly 213,000 shares traded hands.

12 January 2026

NASDAQ:POWL·Stock Market

Hecla Mining (HL) stock jumps as silver hits a fresh record — what investors watch next

Hecla Mining Co shares jumped roughly 9%, reaching about $24.5 in early afternoon trading Monday. The stock hit a session peak close to $24.9. https://www.investing.com/equities/hecla-mining-comp-historical-data

12 January 2026

Commodities·NYSE:HL

XPeng (XPEV) stock jumps 8% as flying-car IPO report hits tape, EU tariff rules in focus

Shares of XPeng Inc, listed in the U.S., jumped Monday following a Bloomberg report that the Chinese EV maker tapped JPMorgan and Morgan Stanley to lead an IPO for its flying-car unit in Hong Kong. The stock rose 8.2% to $21.66 in early afternoon trading.

12 January 2026

Electric Vehicles·EU Regulations·NASDAQ:XPEV

VNET stock jumps nearly 10% as China ADRs rally, with CPI next in focus

Shares of VNET Group, Inc climbed roughly 9.6% to $11.43 by early afternoon on Monday, building on a strong recovery in U.S.-listed Chinese stocks. The price hit a peak of $11.48 after starting the day at $10.79.

12 January 2026

NASDAQ:GDS·NASDAQ:VNET·Stock Market

Previous 1 … 272 273 274 275 276 … 610 Next

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100

#2 BUY

AerCap

NYSE: AER 93 / 100

#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100

#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100

#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100

View full portfolio

Shan Ahmed Khan

Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

GeneDx (WGS) stock dives on 2026 guidance despite strong 2025 prelims — what to watch next

Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

Sarepta stock sinks as Elevidys sales miss, flu delays spill into 2026

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Apellis (APLS) stock slides 15% after $689 mln 2025 revenue preview at JPM conference

First Majestic Silver stock jumps 7% as silver rips to a fresh record — what investors watch next

Sibanye Stillwater stock jumps as gold cracks $4,600, putting Jan. 29 strategy update in play

Nebius (NBIS) stock jumps on report of 800MW Kansas City-area data center plan

Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

IREN Limited stock pops 10% as bitcoin firms and CPI risk hangs over crypto names

Nextpower (NXT) stock jumps on Saudi joint venture launch and 12‑GW factory plan

Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Powell Industries stock jumps as Wall Street Zen upgrade puts POWL back in play

Hecla Mining (HL) stock jumps as silver hits a fresh record — what investors watch next

XPeng (XPEV) stock jumps 8% as flying-car IPO report hits tape, EU tariff rules in focus

VNET stock jumps nearly 10% as China ADRs rally, with CPI next in focus

TechStock² Updates

Super Micro Computer, Inc. (NASDAQ:SMCI) Stock Comes Under Pressure as Cash-Flow Concerns Emerge Despite Margin Recovery

Nu Holdings Ltd. (NYSE:NU) Nears Mexico Bank Rollout, Puts Stock Price Under Scrutiny

SK hynix (KRX:000660) approaches ADR convergence milestone following 30% rally in Seoul

BP (LON:BP) North Sea deal may account for 10%-13% of disposal target ahead of Q2 report

Bristol Myers Squibb (NYSE:BMY) faces valuation test Monday as report of potential partnership emerges

Top Stock Picks

Xylem

AerCap

Visa

Chevron

UPS

Live updates

Investment Disclaimer